193
person
Ivan Soto-Wright
Soto-Wright is a leading financial technology entrepreneur and investor. Throughout his career, h
e has advocated for building systems and developing technologies that increase financial freedom.
+ Read More
person
Megan B. Miller, PhD
Megan B. Miller, PhD, is a socially minded neuroscientist with a passion for brain health advocac
y and strategic planning.
+ Read More
report
State Technology and Science Index 2016: Sustaining Americas Innovation Economy
As the Great Recession recedes in our rearview mirrors, it is becoming ever more apparent that inno
vative activities are determining an increasing proportion of the long-term economic growth of cities, metropolitan areas, regions, states, and even natio
+ Read More
report
Epilepsy - A Giving Smarter Guide
At the time of this report, approximately 30 to 40 percent of epilepsy patients were treatment resi
stant. The most catastrophic forms of epilepsy occur in very young children and have a lifelong negative impact on patients, families, an
+ Read More
report
State Technology and Science Index 2016: California Perspectives
The Milken Institute’s State Technology and Science Index (STSI) series benchmarks states
on their science and technology capacity.
+ Read More
report
Comment Letter to the FDIC: Proposed Guidance for Third-Party Lending
The Milken Institute Center for Financial Markets provided comments to the Federal Deposit Insuranc
e Corporation (FDIC) request for comment on proposed guidance for third-party lending.
+ Read More
report
The CEQA Labyrinth: Fixing the Flaws in a Good Law
Passed in 1970, the California Environmental Quality Act (CEQA) is the state’s broadest environment
al law.
+ Read More
report
Demographic Reporting and Mix in Clinical Trials
Clinical trial enrollment can vary based on demographics. Cancer drug trials, for example, have bee
n shown to skew disproportionately toward young, White, male participants.
+ Read More
report
Innovative Finance Models for Global Early Warning Systems for Pandemics
Despite lessons learned from COVID-19 and other outbreaks, the world remains ill-prepared for the n
ext pandemic.
+ Read More
report
Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard
Since early in the COVID-19 pandemic, FasterCures has been committed to capturing lessons learned a
nd opportunities to improve the biomedical research ecosystem.
+ Read More
report
Corporate Philanthropy: Emerging Strategies for Lasting Impact
Corporate philanthropy is in transition. External trends and heightened stakeholder expectations ha
ve placed new pressures on the corporate sector.
+ Read More